Resultados da pesquisa - Joanna Roder

  • A mostrar 1 - 6 resultados de 6
Refinar resultados
  1. 1
    A Retrospective Analysis of VeriStrat Status on Outcome of a Randomized Phase II Trial of First-Line Therapy with Gemcitabine, Erlotinib, or the Combination in Elderly Patients (Age 70 Years or Older) with Stage IIIB/IV Non–Small-Cell Lung Cancer

    A Retrospective Analysis of VeriStrat Status on Outcome of a Randomized Phase II Trial of First-Line Therapy with Gemcitabine, Erlotinib, or the Combination in Elderly Patients (Ag... Por Thomas E. Stinchcombe, Joanna Roder, Amy H. Peterman, Julia Grigorieva, Carrie B. Lee, Dominic T. Moore, Mark A. Socinski

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in the NCIC Clinical Trials Group BR.21 Trial

    Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in the NCIC Clinical Trials Group... Por David P. Carbone, Keyue Ding, Heinrich Röder, Julia Grigorieva, Joanna Roder, Ming‐Sound Tsao, Lesley Seymour, Frances A. Shepherd

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

    The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients Por Mary J. Fidler, Cristina Fhied, Joanna Roder, Sanjib Basu, Selina Sayidine, Ibtihaj Fughhi, Mark Pool, Marta Batus, Philip Bonomi, Jeffrey A. Borgia

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Detection of Tumor Epidermal Growth Factor Receptor Pathway Dependence by Serum Mass Spectrometry in Cancer Patients

    Detection of Tumor Epidermal Growth Factor Receptor Pathway Dependence by Serum Mass Spectrometry in Cancer Patients Por Christine H. Chung, Erin H. Seeley, Heinrich Röder, Julia Grigorieva, Maxim Tsypin, Joanna Roder, Barbara Burtness, Athanassios Argiris, Arlene A. Forastiere, Jill Gilbert, Barbara A. Murphy, Richard M. Caprioli, David P. Carbone, Ezra E.W. Cohen

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    A Serum Protein Signature Associated with Outcome after Anti–PD-1 Therapy in Metastatic Melanoma

    A Serum Protein Signature Associated with Outcome after Anti–PD-1 Therapy in Metastatic Melanoma Por Jeffrey S. Weber, Mario Sznol, Ryan J. Sullivan, Shauna Blackmon, Genevieve M. Boland, Harriet M. Kluger, Ruth Halaban, Antonietta Bacchiocchi, Paolo A. Ascierto, Mariaelena Capone, Carlos Oliveira, Krista Meyer, Julia Grigorieva, Senait Asmellash, Joanna Roder, Heinrich Röder

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial

    Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised... Por Vanesa Gregorc, Silvia Novello, Chiara Lazzari, Sandro Barni, Michele Aieta, Manlio Mencoboni, Francesco Grossi, Tommaso De Pas, Filippo de Marinis, Alessandra Bearz, Irene Floriani, Valter Torri, Alessandra Bulotta, Angela Cattaneo, Julia Grigorieva, Maxim Tsypin, Joanna Roder, Claudio Doglioni, Matteo Giaj Levra, Fausto Petrelli, Silvia Foti, Mariagrazia Viganò, Angela Bachi, Heinrich Röder

    Publicado em 2014
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: